Fieldpoint Private Securities’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$847K Buy
15,194
+5,592
+58% +$312K 0.25% 99
2022
Q1
$533K Sell
9,602
-6,290
-40% -$349K 0.11% 193
2021
Q4
$890K Buy
15,892
+6,934
+77% +$388K 0.17% 137
2021
Q3
$430K Buy
8,958
+1,034
+13% +$49.6K 0.1% 221
2021
Q2
$397K Buy
7,924
+488
+7% +$24.4K 0.09% 230
2021
Q1
$251K Buy
7,436
+3,446
+86% +$116K 0.06% 261
2020
Q4
$139K Buy
+3,990
New +$139K 0.03% 342
2019
Q2
Sell
-610
Closed -$16K 718
2019
Q1
$16K Hold
610
0.01% 342
2018
Q4
$14K Buy
+610
New +$14K 0.01% 341
2018
Q2
Sell
-15,162
Closed -$373K 418
2018
Q1
$373K Buy
15,162
+1,416
+10% +$34.8K 0.17% 124
2017
Q4
$369K Sell
13,746
-1,684
-11% -$45.2K 0.19% 120
2017
Q3
$371K Buy
15,430
+11,430
+286% +$275K 0.16% 136
2017
Q2
$86K Buy
4,000
+3,530
+751% +$75.9K 0.06% 95
2017
Q1
$8K Buy
+470
New +$8K 0.01% 316